| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0066 | 0.8 |